Why we should use mild stimulation in egg donation
By Guido Pennings,
BioNews
| 11. 30. 2020
There are two strong ethical reasons to avoid harm to egg donors: a duty to minimise harm and the proportionality rule. The general duty to minimise harm applies to all medical interventions but it is even more relevant for donors because they are submitting to the intervention for the benefit of others. Most forms of body material donation will carry with them some harm. This duty does not make that unacceptable but implies that harm is only acceptable when it is unavoidable, and this duty cannot be bypassed by asking the donor for consent. The informed consent form is not a safe conduct for high risks.
Whenever you mention ovarian hyperstimulation syndrome (OHSS) to a clinician, they will reply that it was indeed a serious problem in the past but that it is under control now. The current stimulation protocols bring the risk of OHSS down to zero. However, one wonders how the statistics can be explained as data from the European IVF-Monitoring Consortium show that severe OHSS has not disappeared. Moreover, the American Society for Reproductive Medicine recently calculated that...
Related Articles
By Marisa Flook , BioNews | 06.29.2026
An anti-ageing gene therapy not approved by the US Food and Drug Administration (FDA) is set to be offered by an American company at overseas clinics outside of US jurisdiction.
The treatment, developed by Minicircle from Austin, Texas, uses a...
By Philip Ball , Nature | 06.17.2026
Our genomes are full of mutations that have the potential to damage our health or even kill us. Yet most of them rarely cause problems. Why? It’s partly thanks to a family of proteins that mask, or ‘buffer’, the ill...
By Philip Ball, Quanta Magazine | 06.18.2026
Since its molecular structure was deduced in the 1950s, DNA has been hailed by many biologists as the secret of life. They’ve read and studied the information stored in the DNA found in the cells of living organisms, known as...
By Arche Noah, GMWatch | 06.17.2026
The European Parliament has voted for a wide-reaching deregulation of New Genomic Techniques (NGTs). There was no majority for amendments stopping patents on conventionally classically bred plants or NGT plants. “Today’s vote is a missed opportunity to protect Europe’s farmers...